Sign in

CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Design Therapeutics, Inc.

Sign in to watch
Ticker
DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823929248
Phone
858-293-4900
Business address
6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. CERT Other Certification
  13. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  14. 8-A12B Other Registration of Securities
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1/A Offering Registration Statement
  19. UPLOAD Other SEC-generated Letter
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 13 of 14 · 268 filings